Bionical Solutions, a UK-based company that provides technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the UK NHS, announced on Thursday that it has named Tom Tacon as its new business unit director of Bionical Virtual Engagement, formerly Bionical Solutions Commercial business, effective 1 July.

Tacon, a skilled sales and marketing executive, has around two decades' experience working for blue chip pharma and med tech companies, which includes Daichi Sankyo, Coloplast, Boehringer Ingelheim and GSK.

Gareth Davies, joint CEO at Bionical Solutions, said, 'Tom's appointment comes at an exciting time for Bionical Virtual Engagement as it forges an independent path providing an essential service to pharma, medtech and healthcare companies looking to enhance engagement with prescribers. Tom's huge experience leading sales teams and setting up multi-channel engagement strategies will be of enormous benefit to the company and our clients.'